An economic evaluation and incremental analysis of the cost effectiveness of three universal childhood varicella vaccination strategies for Ireland.
Name:
Publisher version
View Source
Access full-text PDFOpen Access
View Source
Check access options
Check access options
Affiliation
Health Information and Quality AuthorityIssue Date
2024-04-11Keywords
CHICKENPOXCost effectiveness
ECONOMIC EVALUATION
IMMUNISATION
VACCINATION
vaccine
VARICELLA
Metadata
Show full item recordPublisher
ElsevierJournal
VaccineDOI
10.1016/j.vaccine.2024.04.027PubMed ID
38609807Item Type
ArticleLanguage
enEISSN
1873-2518ae974a485f413a2113503eed53cd6c53
10.1016/j.vaccine.2024.04.027
Scopus Count
Collections
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as Copyright © 2024. Published by Elsevier Ltd.
Related articles
- Cost-effectiveness of varicella and herpes zoster vaccination in Sweden: An economic evaluation using a dynamic transmission model.
- Authors: Wolff E, Widgren K, Scalia Tomba G, Roth A, Lep T, Andersson S
- Issue date: 2021
- Cost effectiveness and budget impact of universal varicella vaccination in Russia.
- Authors: Marijam A, Safonova E, Scherbakov M, Shpeer E, Van Oorschot D, Rudakova A, Tatochenko V, Briko N
- Issue date: 2022 Nov 30
- The epidemiologic and economic impact of varicella and herpes zoster vaccination in South Korea: A mathematical modelling study.
- Authors: Kim S, Choi JK, Suh J, Park SH, Lee J
- Issue date: 2024 Jul 25
- Childhood varicella-zoster virus vaccination in Belgium: cost-effective only in the long run or without exogenous boosting?
- Authors: Bilcke J, van Hoek AJ, Beutels P
- Issue date: 2013 Apr
- Cost-effectiveness of varicella vaccine against herpes zoster and post-herpetic neuralgia for elderly in Japan.
- Authors: Hoshi SL, Kondo M, Okubo I
- Issue date: 2017 May 31